|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Varicella-Zoster Virus (VZV) Antibodies (Total, IgM), ACIF/IFA, CSF
Test Code34972
CPT Codes
86787 (x2)
Includes
Varicella-Zoster Virus Antibody, ACIF, CSF
Varicella-Zoster Virus Antibody (IgM), IFA, CSF
Varicella-Zoster Virus Antibody (IgM), IFA, CSF
Preferred Specimen
0.5 mL CSF collected in a sterile leak-proof container
Minimum Volume
0.2 mL
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Grossly icteric
Methodology
Anti-Complement Immunofluorescence (ACIF) • Indirect Fluorescent Antibody (IFA)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Tues-Sat; Report available: 1-3 days
Reference Range
Varicella Zoster Virus Ab, Total ACIF, CSF | <1:2 |
Varicella Zoster Virus Ab (IgM), IFA, CSF | <1:1 |
Clinical Significance
Detection of intrathecally-produced organism-specific antibodies in CSF indicates central nervous system infection. However, serum levels of organism-specific antibodies, blood-brain barrier integrity, and possible CSF contamination by blood should be considered when assessing CSF results.